Dr Lindner, it is exciting to see how far we have advanced in cancer research in recent decades. Cancer genomics and surveillance have evolved in the ability to detect breast and cervical cancer, where do you see the propensity for early ovarian cancer detection? How do you see the direction of cancer genomics trending in the next 5 to 10 years?
Deborah Lindner, MD
Expert in Hereditary Breast and Ovarian Cancer
M.D. Candidate. Biomedical researcher. Passions: health equity | brain health | public health | healthcare innovation | art | music | fitness
- All Questions & Answers
- Question: Day 5: Cancer Genomics and Personalized Medicine with Dr. Deborah Lindner
Time Zone: EST